Microbiotica
Microbiotica is a clinical-stage biopharmaceutical company that translates microbiome science into medicines, developing defined live biotherapeutic products.
Microbiotica has raised €103M across 2 funding rounds from 8 investors, most recently a Series C round in Oct 2026. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.microbiotica.com ↗
Total raised
€103M
€103,175,982
Funding rounds
2
Investors
8
distinct backers
Active since
2022-03
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDMicrobiotica — funding by year — interactive chart.
Data table
| Microbiotica — funding by year | |
|---|---|
| 2022 | €61M |
| 2026 | €43M |
Signals
High confidenceRaise-next likelihood15
base rate 50% for Series C
- ▼ Raised very recently
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood20
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-16 | Series C | €43M | British Business Bank,Cambridge Innovation Capital,Existing investors,Flerie Invest,IP Group,Seventure Partners+1 more | View deal → |
| 2022-03-07 | Series B | €61M | British Patient Capital,Cambridge Innovation Capital,Flerie Invest,IP Group,Seventure Partners,Tencent | View deal → |